Abstract
To assess the risk factors that increase the recurrence rate in the cases treated forstage I cervical cancer. Department of Gynecologic Oncology, SSK Ege Maternity Teaching Hospital. 117 FIGO stage I cervix carcinoma cases were treated between 1986 and 1996 in our clinic. 64.9% (76 /117) of the patients primarily underWent radical hysterectomy and pelvic-paraaortic lymphadenectomy, while radiotherapy was performed to 66% (77/117) cases as phmary oradjuvant treatment modality. Treatment modalities, histologic type, lymph node involvement, invasion findings, and recurrences were documented. Epidermoid carcinoma was found in 103 patients (88.4 %), adenocarcinoma in 13 (10.7 %) and sarcoma in one (0.9%). Fourteen cases were stage Ia1, eight were stage Ia2 and 94 were stage Ib. Lymph node involvement was observed in 41% of the cases having parametrial involvement. Genitourinary fistula was the most encountered morbidity with the rate of 3.9 %. İt is recognised that recurrence and lymph node involvement rates increase when the depth invasion increases. 5-year survival rate was found as 88.56 % in ourseries.
Keywords
EVRE I İNVAZİV SERVİKS KARSİNOMLARI: SSK EGE DOĞUMEVİ VE KADIN HASTALIKLARI EĞİTİM HASTANESİ DENEYİMİ
Abstract
Evre I serviks kanseri nedeniyle tedavi edilen olgularda rekürrens riskini arttıran faktörlerin incelenmesi ve yaşam şansının belirlenmesi. S.S.K. Ege Doğumevi ve Kadın Hastalıkları Eğitim Hastanesi Onkoloji Departmanı. 1986-1996 yılları arasında serviks karsinomu tanısı alan 443 olgudan FIGO sınıflamasına göre evre I grubunda 117 olgu (% 26.4) tedavi edildi. Risk faktörü taşıyan 77 (% 66) olguya radyoterapi uygulandı. Uygulanan tedavi modalitelen, histolojik tip, lenf nodu tutulumu, invazyon bulguları ve rekürrensler dökümante edildi. 103 olguda (%88.4) epidermoid karsinom, 13 olguda (%10.7) adenokarsinom ve 1 olguda (%0.9) sarkom saptandı. 14 olgu evre Ia1, 9 olgu evre Ia2 ve 94 olgu evre Ib olarak değerlendirildi. Invazyon derinliği arttıkça rekürrens ve lenf nodu tutulumunun arttığı gözlendi. Seride 5 yıllık yaşam şansı %88.56 olarak hesaplandı.
Keywords
Details
| Other ID | JA39GN35YA |
|---|---|
| Authors | |
| Submission Date | March 1, 2000 |
| Publication Date | March 1, 2000 |
| IZ | https://izlik.org/JA75HZ79GJ |
| Published in Issue | Year 2000 Volume: 39 Issue: 1 |
Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.